Timothy Stover - 30 Aug 2023 Form 3 Insider Report for NexImmune, Inc.

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
08 Sep 2023, 19:23:59 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nadia Do Canto, Attorney-in-fact

Key filing fact

Timothy Stover filed Form 3 for NexImmune, Inc. on 08 Sep 2023.

Key facts

  • This page summarizes Timothy Stover's Form 3 filing for NexImmune, Inc..
  • 0 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 08 Sep 2023, 19:23.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEXI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
71,000
Date
30 Aug 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEXI holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
13,475
Exercise price
$0.4100
Footnotes
F2
NEXI holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,925
Exercise price
$1.03
Footnotes
F2
NEXI holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,375
Exercise price
$1.03
Footnotes
F3
NEXI holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
32,000
Exercise price
$0.4100
Footnotes
F4
NEXI holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,625
Exercise price
$0.4100
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest 100% on the 18-month anniversary of November 22, 2022, subject to Mr. Stover's continued service through the applicable vesting date.

Footnote F2

25% of this option vested and became exercisable on July 6, 2022, with the remainder vesting in 36 equal monthly installments thereafter.

Footnote F3

25% of this option vested and became exercisable on April 5, 2023, with the remainder vesting in 36 equal monthly installments thereafter.

Footnote F4

25% of this option will vest and become exercisable on April 4, 2024, with the remainder vesting in 36 equal monthly installments thereafter.

SEC remarks

Exhibit 24.1

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .